FdaApplication

ANDA 213547

Back to search

Identifiers

Properties

PropertyValue
applicant_nameQILU PHARMACEUTICAL CO LTD
application_typeANDA
approval_date2020-04-13

Products (1)

ProductActive ingredientStrengthDosage form
EXEMESTANEEXEMESTANE25MGTABLET;ORAL

1 product